Y-Intercept (HK)’s AngioDynamics ANGO Stock Holding History

Y-Intercept (HK)’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.92M	Buy	124,596 +78,328	+169%	+$1.17M	0.04%	653
2026 Q2	$602K	Sell	46,268 -34,123	-42%	-$388K	0.01%	1257
2026 Q1	$914K	Buy	80,391 +12,436	+18%	+$135K	0.02%	1072
2025 Q4	$873K	Buy	67,955 +4,037	+6%	+$49.8K	0.02%	1034
2025 Q3	$714K	Sell	63,918 -160,596	-72%	-$1.55M	0.02%	1123
2025 Q2	$2.23M	Buy	224,514 +201,843	+890%	+$1.98M	0.05%	553
2025 Q1	$213K	Buy	+22,671	New	+$238K	0.01%	1037
2024 Q4	–	Sell	-36,006	Closed	-$280K	–	1152
2024 Q3	$280K	Buy	+36,006	New	+$260K	0.02%	1046
2024 Q2	–	Sell	-41,926	Closed	-$246K	–	1366
2024 Q1	$246K	Buy	41,926 +28,336	+209%	+$168K	0.02%	1058
2023 Q4	$107K	Sell	13,590 -17,589	-56%	-$122K	0.01%	1087
2023 Q3	$228K	Buy	+31,179	New	+$259K	0.02%	873

Other funds holding ANGO

Weber Capital Management San Francisco, California $110M AUM 43.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bastion Asset Management Montreal, Canada $229M AUM 5.92% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Y-Intercept (HK)'s ANGO Position: Q3 2026 in Review

Y-Intercept (HK) increased its AngioDynamics (ANGO) stake by 169% in Q3 2026, buying an estimated $1.17M and bringing the position to 124,596 shares worth $1.92M. The position accounts for 0.04% of the portfolio, ranked #653.

Y-Intercept (HK) first reported a position in ANGO in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.23M in Q2 2025. 58 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

Y-Intercept (HK) held 124,596 shares of AngioDynamics worth $1.92M as of Q3 2026.
Y-Intercept (HK) bought 78,328 AngioDynamics shares in Q3 2026, an estimated $1.17M.
AngioDynamics made up 0.04% of Y-Intercept (HK)'s portfolio in Q3 2026, its #653 holding.
Y-Intercept (HK) first reported a position in AngioDynamics in Q3 2023 and has held it in 11 quarters since.
Y-Intercept (HK)'s AngioDynamics position peaked at $2.23M in Q2 2025.
58 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.